APO Research
Talk to an analyst

APO RESEARCH · REPORT

Macrolide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Macrolide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchMacrolide Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Macrolide Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Macrolide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Macrolide Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Macrolide Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Macrolide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Macrolide Drugs include Teva Pharmaceutical Industries, Sanofi, Merck & Co., Mylan, Pfizer, Fresenius Kabi, WOCKHARDT, Tacorolimus and Sirolimus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Macrolide Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Macrolide Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Macrolide Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Macrolide Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Macrolide Drugs Segment by Company

Teva Pharmaceutical Industries

Sanofi

Merck & Co.

Mylan

Pfizer

Fresenius Kabi

WOCKHARDT

Tacorolimus

Sirolimus

Sandoz International

Neo Química

Macrolide Pharmaceuticals

Gland Pharmm

Eli Lilly & Co.

Akorn

Abbott Laboratories

Macrolide Drugs Segment by Type

14-Membered Ring Agents

15-Membered Ring Agents

16-Membered Ring Agents

Ketolides

Macrolide Drugs Segment by Application

Clinics

Hospitalshospital Pharmacies

Hospitals

Online Pharmacies

Retail Pharmacies

Macrolide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Macrolide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Macrolide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Macrolide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Macrolide Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Macrolide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Macrolide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Macrolide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Macrolide Drugs Industry Trends Table 2. Macrolide Drugs Industry Drivers Table 3. Macrolide Drugs Industry Opportunities and Challenges Table 4. Macrolide Drugs Industry Restraints Table 5. Global Macrolide Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Macrolide Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Macrolide Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Macrolide Drugs Sales Market Share by Manufacturers Table 9. Global Macrolide Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Macrolide Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Macrolide Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Macrolide Drugs Manufacturers, Product Type & Application Table 13. Global Macrolide Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Macrolide Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 14-Membered Ring Agents Table 17. Major Manufacturers of 15-Membered Ring Agents Table 18. Major Manufacturers of 16-Membered Ring Agents Table 19. Major Manufacturers of Ketolides Table 20. Global Macrolide Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 22. Global Macrolide Drugs Sales by Type (2027-2032) & (k units) Table 23. Global Macrolide Drugs Sales Market Share by Type (2021-2026) Table 24. Global Macrolide Drugs Sales Market Share by Type (2027-2032) Table 25. Global Macrolide Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Macrolide Drugs Revenue by Type (2021-2026) & (k units) Table 27. Global Macrolide Drugs Revenue by Type (2027-2032) & (k units) Table 28. Global Macrolide Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Macrolide Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Hospitalshospital Pharmacies Table 32. Major Manufacturers of Hospitals Table 33. Major Manufacturers of Online Pharmacies Table 34. Major Manufacturers of Retail Pharmacies Table 35. Global Macrolide Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 37. Global Macrolide Drugs Sales by Application (2027-2032) & (k units) Table 38. Global Macrolide Drugs Sales Market Share by Application (2021-2026) Table 39. Global Macrolide Drugs Sales Market Share by Application (2027-2032) Table 40. Global Macrolide Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Macrolide Drugs Revenue by Application (2021-2026) & (k units) Table 42. Global Macrolide Drugs Revenue by Application (2027-2032) & (k units) Table 43. Global Macrolide Drugs Revenue Market Share by Application (2021-2026) Table 44. Global Macrolide Drugs Revenue Market Share by Application (2027-2032) Table 45. Global Macrolide Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Macrolide Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Macrolide Drugs Sales Market Share by Region (2021-2026) Table 48. Global Macrolide Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Macrolide Drugs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 52. North America Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 53. Europe Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 55. Europe Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 62. Global Macrolide Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Macrolide Drugs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Macrolide Drugs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Macrolide Drugs Revenue Market Share by Region (2021-2026) Table 66. Global Macrolide Drugs Revenue Market Share by Region (2027-2032) Table 67. Teva Pharmaceutical Industries Company Information Table 68. Teva Pharmaceutical Industries Business Overview Table 69. Teva Pharmaceutical Industries Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio Table 71. Teva Pharmaceutical Industries Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi Macrolide Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. Merck & Co. Company Information Table 78. Merck & Co. Business Overview Table 79. Merck & Co. Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Merck & Co. Macrolide Drugs Product Portfolio Table 81. Merck & Co. Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Macrolide Drugs Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Macrolide Drugs Product Portfolio Table 91. Pfizer Recent Development Table 92. Fresenius Kabi Company Information Table 93. Fresenius Kabi Business Overview Table 94. Fresenius Kabi Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Fresenius Kabi Macrolide Drugs Product Portfolio Table 96. Fresenius Kabi Recent Development Table 97. WOCKHARDT Company Information Table 98. WOCKHARDT Business Overview Table 99. WOCKHARDT Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. WOCKHARDT Macrolide Drugs Product Portfolio Table 101. WOCKHARDT Recent Development Table 102. Tacorolimus Company Information Table 103. Tacorolimus Business Overview Table 104. Tacorolimus Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Tacorolimus Macrolide Drugs Product Portfolio Table 106. Tacorolimus Recent Development Table 107. Sirolimus Company Information Table 108. Sirolimus Business Overview Table 109. Sirolimus Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Sirolimus Macrolide Drugs Product Portfolio Table 111. Sirolimus Recent Development Table 112. Sandoz International Company Information Table 113. Sandoz International Business Overview Table 114. Sandoz International Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Sandoz International Macrolide Drugs Product Portfolio Table 116. Sandoz International Recent Development Table 117. Neo Química Company Information Table 118. Neo Química Business Overview Table 119. Neo Química Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Neo Química Macrolide Drugs Product Portfolio Table 121. Neo Química Recent Development Table 122. Macrolide Pharmaceuticals Company Information Table 123. Macrolide Pharmaceuticals Business Overview Table 124. Macrolide Pharmaceuticals Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio Table 126. Macrolide Pharmaceuticals Recent Development Table 127. Gland Pharmm Company Information Table 128. Gland Pharmm Business Overview Table 129. Gland Pharmm Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Gland Pharmm Macrolide Drugs Product Portfolio Table 131. Gland Pharmm Recent Development Table 132. Eli Lilly & Co. Company Information Table 133. Eli Lilly & Co. Business Overview Table 134. Eli Lilly & Co. Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Eli Lilly & Co. Macrolide Drugs Product Portfolio Table 136. Eli Lilly & Co. Recent Development Table 137. Akorn Company Information Table 138. Akorn Business Overview Table 139. Akorn Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Akorn Macrolide Drugs Product Portfolio Table 141. Akorn Recent Development Table 142. Abbott Laboratories Company Information Table 143. Abbott Laboratories Business Overview Table 144. Abbott Laboratories Macrolide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Abbott Laboratories Macrolide Drugs Product Portfolio Table 146. Abbott Laboratories Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Macrolide Drugs Distributors List Table 150. Macrolide Drugs Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Macrolide Drugs Product Image Figure 2. Global Macrolide Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Macrolide Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Macrolide Drugs Sales (2021-2032) & (k units) Figure 5. Global Macrolide Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Macrolide Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 14-Membered Ring Agents Image Figure 9. 15-Membered Ring Agents Image Figure 10. 16-Membered Ring Agents Image Figure 11. Ketolides Image Figure 12. Global Macrolide Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Macrolide Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Macrolide Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Macrolide Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Macrolide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Macrolide Drugs Revenue Market Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitalshospital Pharmacies Image Figure 20. Hospitals Image Figure 21. Online Pharmacies Image Figure 22. Retail Pharmacies Image Figure 23. Global Macrolide Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Macrolide Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Macrolide Drugs Sales Market Share by Application (2021-2032) Figure 26. Global Macrolide Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Macrolide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Macrolide Drugs Revenue Market Share by Application (2021-2032) Figure 29. North America Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 31. U.S. Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 36. Germany Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 43. China Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 51. Brazil Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Macrolide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Macrolide Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Macrolide Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Macrolide Drugs Revenue (2021-2032) & (US$ Million) Figure 62. North America Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Macrolide Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Macrolide Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Macrolide Drugs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Macrolide Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Macrolide Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 14-Membered Ring Agents
  • 15-Membered Ring Agents
  • 16-Membered Ring Agents
  • Ketolides
Applications
  • Clinics
  • Hospitalshospital Pharmacies
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Merck & Co.
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • WOCKHARDT
  • Tacorolimus
  • Sirolimus
  • Sandoz International
  • Neo Química
  • Macrolide Pharmaceuticals
  • Gland Pharmm
  • Eli Lilly & Co.
  • Akorn
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Macrolide Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Macrolide Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Macrolide Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Macrolide Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Macrolide Drugs Market Dynamics
  1. 2.1 Macrolide Drugs Industry Trends
  2. 2.2 Macrolide Drugs Industry Drivers
  3. 2.3 Macrolide Drugs Industry Opportunities and Challenges
  4. 2.4 Macrolide Drugs Industry Restraints
3 Macrolide Drugs Market by Manufacturers
  1. 3.1 Global Macrolide Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Macrolide Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Macrolide Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Macrolide Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Macrolide Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Macrolide Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Macrolide Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Macrolide Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Macrolide Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Macrolide Drugs Tier 1, Tier 2, and Tier 3
4 Macrolide Drugs Market by Type
  1. 4.1 Macrolide Drugs Type Introduction
  2. 4.1.1 14-Membered Ring Agents
  3. 4.1.2 15-Membered Ring Agents
  4. 4.1.3 16-Membered Ring Agents
  5. 4.1.4 Ketolides
  6. 4.2 Global Macrolide Drugs Sales by Type
  7. 4.2.1 Global Macrolide Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Macrolide Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Macrolide Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Macrolide Drugs Revenue by Type
  11. 4.3.1 Global Macrolide Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Macrolide Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Macrolide Drugs Revenue Market Share by Type (2021-2032)
5 Macrolide Drugs Market by Application
  1. 5.1 Macrolide Drugs Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitalshospital Pharmacies
  4. 5.1.3 Hospitals
  5. 5.1.4 Online Pharmacies
  6. 5.1.5 Retail Pharmacies
  7. 5.2 Global Macrolide Drugs Sales by Application
  8. 5.2.1 Global Macrolide Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Macrolide Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global Macrolide Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Macrolide Drugs Revenue by Application
  12. 5.3.1 Global Macrolide Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Macrolide Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global Macrolide Drugs Revenue Market Share by Application (2021-2032)
6 Global Macrolide Drugs Sales by Region
  1. 6.1 Global Macrolide Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Macrolide Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Macrolide Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Macrolide Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Macrolide Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Macrolide Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Macrolide Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Macrolide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Macrolide Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Macrolide Drugs Revenue by Region
  1. 7.1 Global Macrolide Drugs Revenue by Region
  2. 7.1.1 Global Macrolide Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Macrolide Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Macrolide Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Macrolide Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Macrolide Drugs Revenue (2021-2032)
  8. 7.2.2 North America Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Macrolide Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Macrolide Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Macrolide Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Macrolide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Macrolide Drugs Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Merck & Co.
  14. 8.3.1 Merck & Co. Company Information
  15. 8.3.2 Merck & Co. Business Overview
  16. 8.3.3 Merck & Co. Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co. Macrolide Drugs Product Portfolio
  18. 8.3.5 Merck & Co. Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Macrolide Drugs Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Macrolide Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Macrolide Drugs Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 WOCKHARDT
  38. 8.7.1 WOCKHARDT Company Information
  39. 8.7.2 WOCKHARDT Business Overview
  40. 8.7.3 WOCKHARDT Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 WOCKHARDT Macrolide Drugs Product Portfolio
  42. 8.7.5 WOCKHARDT Recent Developments
  43. 8.8 Tacorolimus
  44. 8.8.1 Tacorolimus Company Information
  45. 8.8.2 Tacorolimus Business Overview
  46. 8.8.3 Tacorolimus Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tacorolimus Macrolide Drugs Product Portfolio
  48. 8.8.5 Tacorolimus Recent Developments
  49. 8.9 Sirolimus
  50. 8.9.1 Sirolimus Company Information
  51. 8.9.2 Sirolimus Business Overview
  52. 8.9.3 Sirolimus Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sirolimus Macrolide Drugs Product Portfolio
  54. 8.9.5 Sirolimus Recent Developments
  55. 8.10 Sandoz International
  56. 8.10.1 Sandoz International Company Information
  57. 8.10.2 Sandoz International Business Overview
  58. 8.10.3 Sandoz International Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sandoz International Macrolide Drugs Product Portfolio
  60. 8.10.5 Sandoz International Recent Developments
  61. 8.11 Neo Química
  62. 8.11.1 Neo Química Company Information
  63. 8.11.2 Neo Química Business Overview
  64. 8.11.3 Neo Química Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Neo Química Macrolide Drugs Product Portfolio
  66. 8.11.5 Neo Química Recent Developments
  67. 8.12 Macrolide Pharmaceuticals
  68. 8.12.1 Macrolide Pharmaceuticals Company Information
  69. 8.12.2 Macrolide Pharmaceuticals Business Overview
  70. 8.12.3 Macrolide Pharmaceuticals Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio
  72. 8.12.5 Macrolide Pharmaceuticals Recent Developments
  73. 8.13 Gland Pharmm
  74. 8.13.1 Gland Pharmm Company Information
  75. 8.13.2 Gland Pharmm Business Overview
  76. 8.13.3 Gland Pharmm Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gland Pharmm Macrolide Drugs Product Portfolio
  78. 8.13.5 Gland Pharmm Recent Developments
  79. 8.14 Eli Lilly & Co.
  80. 8.14.1 Eli Lilly & Co. Company Information
  81. 8.14.2 Eli Lilly & Co. Business Overview
  82. 8.14.3 Eli Lilly & Co. Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eli Lilly & Co. Macrolide Drugs Product Portfolio
  84. 8.14.5 Eli Lilly & Co. Recent Developments
  85. 8.15 Akorn
  86. 8.15.1 Akorn Company Information
  87. 8.15.2 Akorn Business Overview
  88. 8.15.3 Akorn Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Akorn Macrolide Drugs Product Portfolio
  90. 8.15.5 Akorn Recent Developments
  91. 8.16 Abbott Laboratories
  92. 8.16.1 Abbott Laboratories Company Information
  93. 8.16.2 Abbott Laboratories Business Overview
  94. 8.16.3 Abbott Laboratories Macrolide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Abbott Laboratories Macrolide Drugs Product Portfolio
  96. 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Macrolide Drugs Value Chain Analysis
  2. 9.1.1 Macrolide Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Macrolide Drugs Production Mode & Process
  6. 9.2 Macrolide Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Macrolide Drugs Distributors
  9. 9.2.3 Macrolide Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst